Industrial-scale genome sequencing
Gencove has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in October 2021.
Gencove's investors include SV Angel, Version One Ventures, Refactor, Lewis & Clark AgriFood, Alexandria Venture Investments.
Gencove is headquartered in New York, United States.
Industrial-scale genome sequencing
Gencove is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gencove — Funding & Investors." VCBacked, October 26, 2021, https://www.vcbacked.co/company/gencove. Accessed July 19, 2026.
VCBacked. (2021). Gencove — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/gencove
{{cite web |title=Gencove — Funding & Investors |url=https://www.vcbacked.co/company/gencove |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated